Outset Medical Q1 2024 Adj EPS $(0.57) Misses $(0.55) Estimate, Sales $28.168M Miss $30.341M Estimate
Outset Medical Q1 2024 Adj EPS $(0.57) Misses $(0.55) Estimate, Sales $28.168M Miss $30.341M Estimate
Outset Medical 2024年第一季度調整後每股收益美元（0.57）未達到預期（0.55），銷售額爲2816.8萬美元，低於3,0341萬美元的預期
Outset Medical (NASDAQ:OM) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.55) by 3.64 percent. This is a 20.83 percent increase over losses of $(0.72) per share from the same period last year. The company reported quarterly sales of $28.168 million which missed the analyst consensus estimate of $30.341 million by 7.16 percent. This is a 15.83 percent decrease over sales of $33.467 million the same period last year.
Outset Medical（納斯達克股票代碼：OM）公佈的季度虧損爲每股0.57美元，比分析師普遍預期的0.55美元（0.55美元）低3.64％。這比去年同期每股虧損0.72美元（0.72美元）增長了20.83％。該公司公佈的季度銷售額爲2816.8億美元，比分析師普遍預期的303.41億美元低7.16％。這比去年同期的3,346.7萬美元的銷售額下降了15.83％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。